Src Inhibition Ameliorates Polycystic Kidney Disease
Open Access
- 1 July 2008
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Society of Nephrology
- Vol. 19 (7), 1331-1341
- https://doi.org/10.1681/asn.2007060665
Abstract
Despite identification of the genes responsible for autosomal dominant polycystic kidney disease (PKD) and autosomal recessive PKD (ARPKD), the precise functions of their cystoprotein products remain unknown. Recent data suggested that multimeric cystoprotein complexes initiate aberrant signaling cascades in PKD, and common components of these signaling pathways may be therapeutic targets. This study identified c-Src (pp60c-Src) as one such common signaling intermediate and sought to determine whether Src activity plays a role in cyst formation. With the use of the nonorthologous BPK murine model and the orthologous PCK rat model of ARPKD, greater Src activity was found to correlate with disease progression. Inhibition of Src activity with the pharmacologic inhibitor SKI-606 resulted in amelioration of renal cyst formation and biliary ductal abnormalities in both models. Furthermore, the effects of Src inhibition in PCK kidneys suggest that the ErbB2 and B-Raf/MEK/ERK pathways are involved in Src-mediated signaling in ARPKD and that this occurs without reducing elevated cAMP. These data suggest that Src inhibition may provide therapeutic benefit in PKD.Keywords
This publication has 44 references indexed in Scilit:
- Molecular and cellular pathophysiology of autosomal recessive polycystic kidney disease (ARPKD)Cell and tissue research, 2006
- Activation of the MEK5/ERK5 Cascade Is Responsible for Biliary Dysgenesis in a Rat Model of Caroli's DiseaseThe American Journal of Pathology, 2005
- Epidermal growth factor receptor tyrosine kinase inhibition is not protective in PCK ratsKidney International, 2004
- Polycystic kidney disease: new understanding in the pathogenesisThe International Journal of Biochemistry & Cell Biology, 2004
- Calcium Restriction Allows cAMP Activation of the B-Raf/ERK Pathway, Switching Cells to a cAMP-dependent Growth-stimulated PhenotypePublished by Elsevier BV ,2004
- Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cellsKidney International, 2004
- Combination treatment of PKD utilizing dual inhibition of EGF-receptor activity and ligand bioavailabilityKidney International, 2003
- Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitorKidney International, 2000
- Characterization of a Novel Polycystic Kidney Rat Model with Accompanying Polycystic Liver.Experimental Animals, 2000
- Identification of Phosphorylation Sites in the PKD1-Encoded Protein C-Terminal DomainBiochemical and Biophysical Research Communications, 1999